CA2002218A1 - Neoglycoproteines, preparation et utilisation - Google Patents
Neoglycoproteines, preparation et utilisationInfo
- Publication number
- CA2002218A1 CA2002218A1 CA2002218A CA2002218A CA2002218A1 CA 2002218 A1 CA2002218 A1 CA 2002218A1 CA 2002218 A CA2002218 A CA 2002218A CA 2002218 A CA2002218 A CA 2002218A CA 2002218 A1 CA2002218 A1 CA 2002218A1
- Authority
- CA
- Canada
- Prior art keywords
- neoglycoproteins
- preparation
- monosialolactose
- disialolactose
- hsa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 3
- 108090000288 Glycoproteins Proteins 0.000 title abstract 3
- 102000008100 Human Serum Albumin Human genes 0.000 abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 102000004856 Lectins Human genes 0.000 abstract 1
- 108090001090 Lectins Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 210000003022 colostrum Anatomy 0.000 abstract 1
- 235000021277 colostrum Nutrition 0.000 abstract 1
- 230000008878 coupling Effects 0.000 abstract 1
- 238000010168 coupling process Methods 0.000 abstract 1
- 238000005859 coupling reaction Methods 0.000 abstract 1
- 239000002523 lectin Substances 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 230000004807 localization Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001169—Tumor associated carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3837623A DE3837623A1 (de) | 1988-11-05 | 1988-11-05 | Neoglykoproteine, ihre herstellung und verwendung |
DEP3837623.7 | 1988-11-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2002218A1 true CA2002218A1 (fr) | 1990-05-05 |
CA2002218C CA2002218C (fr) | 2000-08-08 |
Family
ID=6366580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002002218A Expired - Fee Related CA2002218C (fr) | 1988-11-05 | 1989-11-03 | Neoglycoproteines, preparation et utilisation |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0368131B1 (fr) |
JP (1) | JP2838147B2 (fr) |
KR (1) | KR0162635B1 (fr) |
AT (1) | ATE142229T1 (fr) |
AU (1) | AU630634B2 (fr) |
CA (1) | CA2002218C (fr) |
DE (2) | DE3837623A1 (fr) |
DK (1) | DK549589A (fr) |
ES (1) | ES2093612T3 (fr) |
GR (1) | GR3021111T3 (fr) |
IE (1) | IE76312B1 (fr) |
PT (1) | PT92187B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008203A (en) * | 1995-07-14 | 1999-12-28 | Glycotech Corp. | Methods for treatment of EGF receptor associated cancers |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3840044A1 (de) * | 1988-11-27 | 1990-06-07 | Behringwerke Ag | Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung |
EP0646377A1 (fr) * | 1993-10-01 | 1995-04-05 | LUANFARMA S.r.l. | Extraits de tumeurs exemptes de cellules conjuguées à l'albumine, compositions antigéniques les comprenant, anticorps correspondants, et applications |
US5612030A (en) | 1995-01-17 | 1997-03-18 | University Of Kentucky Research Foundation | Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
US5977316A (en) * | 1995-01-17 | 1999-11-02 | The Board Of Trustees Of The University Of Kentucky | Monoclonal antibody 1A7 and related polypeptides |
US5935821A (en) | 1995-01-17 | 1999-08-10 | Board Of Trustees Of The University Of Kentucky | Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4557931A (en) * | 1982-12-02 | 1985-12-10 | Regents Of The University Of California | Antigenic compositions and methods for using same |
DE3840044A1 (de) * | 1988-11-27 | 1990-06-07 | Behringwerke Ag | Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung |
-
1988
- 1988-11-05 DE DE3837623A patent/DE3837623A1/de not_active Withdrawn
-
1989
- 1989-11-02 ES ES89120245T patent/ES2093612T3/es not_active Expired - Lifetime
- 1989-11-02 AT AT89120245T patent/ATE142229T1/de not_active IP Right Cessation
- 1989-11-02 EP EP89120245A patent/EP0368131B1/fr not_active Expired - Lifetime
- 1989-11-02 JP JP1285094A patent/JP2838147B2/ja not_active Expired - Lifetime
- 1989-11-02 DE DE58909720T patent/DE58909720D1/de not_active Expired - Fee Related
- 1989-11-03 CA CA002002218A patent/CA2002218C/fr not_active Expired - Fee Related
- 1989-11-03 PT PT92187A patent/PT92187B/pt not_active IP Right Cessation
- 1989-11-03 KR KR1019890015922A patent/KR0162635B1/ko not_active IP Right Cessation
- 1989-11-03 IE IE354889A patent/IE76312B1/en not_active IP Right Cessation
- 1989-11-03 DK DK549589A patent/DK549589A/da not_active Application Discontinuation
- 1989-11-03 AU AU44368/89A patent/AU630634B2/en not_active Ceased
-
1996
- 1996-09-19 GR GR960402476T patent/GR3021111T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6008203A (en) * | 1995-07-14 | 1999-12-28 | Glycotech Corp. | Methods for treatment of EGF receptor associated cancers |
US6281202B1 (en) | 1995-07-14 | 2001-08-28 | Glycotech Corp. | Pharmaceutical compositions for treatment of EGF receptor associated cancers |
Also Published As
Publication number | Publication date |
---|---|
EP0368131A2 (fr) | 1990-05-16 |
ES2093612T3 (es) | 1997-01-01 |
DE3837623A1 (de) | 1990-05-10 |
PT92187A (pt) | 1990-05-31 |
DE58909720D1 (de) | 1996-10-10 |
AU630634B2 (en) | 1992-11-05 |
IE893548L (en) | 1990-05-05 |
DK549589A (da) | 1990-05-06 |
GR3021111T3 (en) | 1996-12-31 |
KR900007429A (ko) | 1990-06-01 |
KR0162635B1 (ko) | 1998-11-16 |
ATE142229T1 (de) | 1996-09-15 |
AU4436889A (en) | 1990-05-10 |
DK549589D0 (da) | 1989-11-03 |
JP2838147B2 (ja) | 1998-12-16 |
PT92187B (pt) | 1995-06-30 |
CA2002218C (fr) | 2000-08-08 |
IE76312B1 (en) | 1997-10-22 |
EP0368131A3 (en) | 1990-12-19 |
EP0368131B1 (fr) | 1996-09-04 |
JPH02173000A (ja) | 1990-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5772886A (en) | Novel procoagulant proteins | |
EP0759067A4 (fr) | Facteur transformant de croissance alpha h1 | |
NO884154D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive preparater. | |
FI104255B1 (fi) | Menetelmä ihmisen seerumialbumiinin N-terminaalifragmentteja sisältävien fuusioproteiinien valmistamiseksi | |
AU1130392A (en) | Synthetic htlv-iii peptides, compositions and uses thereof | |
EP0345549A3 (en) | Removal of protein a from antibody preparations | |
AU3125289A (en) | Monoclonal antibodies directed against human tumor necrosis factor - receptor | |
CA2098021A1 (fr) | Composition utilisee comme agent therapeutique contre les hepatopathies virales chroniques | |
CA2149770A1 (fr) | Detection de l'hypoxie | |
AU624436B2 (en) | Albumin preparation and process for preparing the same | |
AU3937289A (en) | Hybrid protein c constructs and methods for their preparation | |
CA2002218A1 (fr) | Neoglycoproteines, preparation et utilisation | |
EP0227619A3 (fr) | Protéine et son application | |
GR3015890T3 (en) | Novel peptides, their use as immuno suppressants and processes for their preparation. | |
CA2139518A1 (fr) | Regions antigeniques des complexes de particules liberes par les tumeurs et anticorps | |
FR2635115B1 (fr) | Procede de preparation de la serum albumine humaine a partir d'une levure | |
EP0209284A3 (fr) | Dérivés de l'anthraquinone | |
AU592023B2 (en) | Synthetic peptide compounds producing antibodies binding to human ldh-c4 | |
AU7633987A (en) | The use of 15-deoxyspergualine as a pharmaceutical | |
EP0213595A3 (fr) | Transferrines et leur application | |
EP0662150A4 (fr) | Maspin, nouveau serpin a activite antitumorale. | |
AU5752490A (en) | A novel tumor associated antigen | |
AU7422387A (en) | Tumor necrosis factor alpha as treatment for infectious diseases | |
AU4668889A (en) | Monoclonal antibodies specific for tumor antigens | |
AU5954990A (en) | Production of antigens by self-assembly of polypeptide components |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |